Home » Topics » Regulatory

Regulatory
RSS

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

New intraocular pressure-lowering agent introduced to Japanese market

July 31, 2001

Genotropin approved in U.S. for growth failure in children born SGA

July 31, 2001

Dutch approval of Remeron SolTab

July 31, 2001

Expanded use of Visudyne approved by Canadian authorities

July 30, 2001

OxyContin labeling changes reflect new FDA warnings

July 27, 2001

Use of BTK inhibitor LFM-A13 for inhibiting platelet aggregation

July 25, 2001

SciClone's lead ISE approved for cancer indication in the Philippines

July 24, 2001

Texas Biotechnology receives approvable letter from FDA for expanded argatroban indication

July 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...